Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Historic FDA Approval Alert!
The FDA has just approved Yeztugo (lenacapavir) – a game-changing HIV prevention drug that offers near-complete protection with just 1 injection every 6 months.
Hailed as the closest thing to an HIV vaccine, this breakthrough could finally help turn the tide on a 45-year pandemic. Unlike traditional PrEP, which requires daily pills, Yeztugo simplifies protection and brings us one step closer to ending HIV for good.”
More posts featuring Yan Leyfman.